Funds and ETFs China NT Pharma Group Company Limited

Equities

1011

KYG2114L1059

Pharmaceuticals

Delayed Hong Kong S.E. 11:36:51 2024-04-28 pm EDT 5-day change 1st Jan Change
0.027 HKD +3.85% Intraday chart for China NT Pharma Group Company Limited +17.39% -50.91%

ETFs positioned on China NT Pharma Group Company Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 117 M€ +1.11% -
CHINA NT PHARMA GROUP COMPANY LIMITED is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in the sales and marketing of miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, as well as sub-licensing of intellectual property rights and distribution rights.
More about the company
  1. Stock Market
  2. Equities
  3. 1011 Stock
  4. Funds and ETFs China NT Pharma Group Company Limited